Canaud, B., Davenport, A., Morena-Carrere, M., Amico, M., Molinari, N., & Cristol, J. Continuous beta-2 microglobulin–based clearance highlights superiority of high-Dose HDF over high-flux HD in predicting outcomes. Nature Portfolio.
Chicago Style (17th ed.) CitationCanaud, Bernard, Andrew Davenport, Marion Morena-Carrere, Mailis Amico, Nicolas Molinari, and Jean-Paul Cristol. Continuous Beta-2 Microglobulin–based Clearance Highlights Superiority of High-Dose HDF over High-flux HD in Predicting Outcomes. Nature Portfolio.
MLA (9th ed.) CitationCanaud, Bernard, et al. Continuous Beta-2 Microglobulin–based Clearance Highlights Superiority of High-Dose HDF over High-flux HD in Predicting Outcomes. Nature Portfolio.
Warning: These citations may not always be 100% accurate.